WAX; Martin B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for WAX; Martin B..The latest application filed is for "ocular formulations for drug-delivery and protection of the anterior segment of the eye".

Company Profile

4.20.42

WAX; Martin B. - Far Hills NJ
Wax; Martin B. - Westlake TX
Wax, Martin B. - Wildwood MO

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Ocular Formulations For Drug-delivery And Protection Of The Anterior Segment Of The Eye App 20210275501 - BINGAMAN; David P. ; et al.	2021-09-09
Ocular Formulations For Drug-delivery To The Posterior Segment Of The Eye App 20210196690 - BINGAMAN; David P. ; et al.	2021-07-01
Ocular Formulations For Drug-delivery And Protection Of The Anterior Segment Of The Eye App 20190314343 - BINGAMAN; David P. ; et al.	2019-10-17
Ocular Formulations For Drug-delivery To The Posterior Segment Of The Eye App 20190247368 - BINGAMAN; David P. ; et al.	2019-08-15
Ocular Formulations For Drug-delivery To The Posterior Segment Of The Eye App 20190240201 - BINGAMAN; David P. ; et al.	2019-08-08
Ocular Formulations For Drug-delivery To The Posterior Segment Of The Eye App 20190183864 - BINGAMAN; David P. ; et al.	2019-06-20
Ocular formulations for drug-delivery to the posterior segment of the eye Grant 10,307,404 - Bingaman , et al.	2019-06-04
Ocular formulations for drug-delivery and protection of the anterior segment of the eye Grant 10,183,014 - Bingaman , et al. Ja	2019-01-22
Ocular formulations for drug-delivery to the posterior segment of the eye Grant 10,092,549 - Bingaman , et al. October 9, 2	2018-10-09
Ocular Formulations For Drug-delivery And Protection Of The Anterior Segment Of The Eye App 20180078531 - BINGAMAN; David P. ; et al.	2018-03-22
Ocular formulations for drug-delivery and protection of the anterior segment of the eye Grant 9,814,702 - Bingaman , et al. November 14, 2	2017-11-14
RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions Grant 9,752,147 - Chatterton , et al. September 5, 2	2017-09-05
Ocular formulations for drug-delivery and protection of the anterior segment of the eye Grant 9,623,011 - Bingaman , et al. April 18, 2	2017-04-18
RNAi-MEDIATED INHIBITION OF CONNEXIN 43 FOR TREATMENT OF IOP-RELATED CONDITIONS App 20170009235 - Chatterton; Jon E. ; et al.	2017-01-12
Ocular Formulations For Drug-delivery To The Posterior Segment Of The Eye App 20160354349 - Bingaman; David P. ; et al.	2016-12-08
RNAi-Related Inhibition of TNF-alpha Signaling Pathway for Treatment of Ocular Angiogenesis App 20160326533 - Chatterton; Jon E. ; et al.	2016-11-10
RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions Grant 9,476,047 - Chatterton , et al. October 25, 2	2016-10-25
Ocular formulations for drug-delivery to the posterior segment of the eye Grant 9,446,026 - Bingaman , et al. September 20, 2	2016-09-20
RNAi-related inhibition of TNF-alpha signaling pathway for treatment of ocular angiogenesis Grant 9,422,556 - Chatterton , et al. August 23, 2	2016-08-23
Ocular Formulations For Drug-delivery And Protection Of The Anterior Segment Of The Eye App 20160206599 - Bingaman; David P. ; et al.	2016-07-21
Ocular Formulations for Drug-Delivery and Protection of the Anterior Segment of the Eye App 20160074371 - Bingaman; David P. ; et al.	2016-03-17
Ocular Formulations for Drug-Delivery to the Posterior Segment of the Eye App 20160022646 - BINGAMAN; David P. ; et al.	2016-01-28
RNAi-MEDIATED INHIBITION OF CONNEXIN 43 FOR TREATMENT OF IOP-RELATED CONDITIONS App 20160002638 - Chatterton; Jon E. ; et al.	2016-01-07
RNAi-Related Inhibition of TNF-alpha Signaling Pathway for Treatment of Ocular Angiogenesis App 20150344886 - Chatterton; Jon E. ; et al.	2015-12-03
RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions Grant 9,173,896 - Chatterton , et al. November 3, 2	2015-11-03
RNAi-related inhibition of TNF alpha signaling pathway for treatment of ocular angiogenesis Grant 9,139,834 - Chatterton , et al. September 22, 2	2015-09-22
RNAi-RELATED INHIBITION OF TNF alpha SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA App 20150057336 - Chatterton; Jon E. ; et al.	2015-02-26
RNAi-RELATED INHIBITION OF TNF alpha SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS App 20140357696 - Chatterton; Jon E. ; et al.	2014-12-04
RNAi-related inhibition of TNF.alpha. signaling pathway for treatment of glaucoma Grant 8,865,670 - Chatterton , et al. October 21, 2	2014-10-21
Ocular Formulations for Drug-Delivery to the Posterior Segment of the Eye App 20140303219 - Bingaman; David P. ; et al.	2014-10-09
RNAi-related inhibition of TNF.alpha. signaling pathway for treatment of ocular angiogenesis Grant 8,754,202 - Chatterton , et al. June 17, 2	2014-06-17
Water insoluble polymer matrix for drug delivery Grant 8,632,809 - Asgharian , et al. January 21, 2	2014-01-21
RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS App 20110257248 - Chatterton; Jon E. ; et al.	2011-10-20
Use Of Multi-pharmacophore Compounds To Treat Nasal Disorders App 20110195962 - Sharif; Najam A. ; et al.	2011-08-11
RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMA App 20110190376 - Chatterton; Jon E. ; et al.	2011-08-04
RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA App 20110135579 - Chatterton; Jon E. ; et al.	2011-06-09
RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS App 20100267811 - Chatterton; Jon E. ; et al.	2010-10-21
Peri-corneal Drug Delivery Device App 20100226962 - Rodstrom; Theron R. ; et al.	2010-09-09
RNAi-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR ALPHA-RELATED CONDITIONS App 20100166676 - Shepard; Allan R. ; et al.	2010-07-01
RNAi-Mediated Inhibition of Ocular Targets App 20090326044 - Shepard; Allan R. ; et al.	2009-12-31
RNAi-mediated inhibition of ocular targets Grant 7,592,324 - Shepard , et al. September 22, 2	2009-09-22
RNAi-MEDIATED INHIBITION OF CONNEXIN 43 FOR TREATMENT OF IOP-RELATED CONDITIONS App 20090209627 - Chatterton; Jon E. ; et al.	2009-08-20
Complement C1Q Inhibitors For The Prevention And Treatment Of Glaucoma App 20090117098 - SHEPARD; Allan R. ; et al.	2009-05-07
Use Of Tnf Receptor Antagonists For Treating Dry Eye App 20090098136 - Gamache; Daniel A. ; et al.	2009-04-16
RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF OCULAR NEOVASCULARIZATION App 20090054365 - Patil; Rajkumar V. ; et al.	2009-02-26
RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA App 20090035225 - Chatterton; Jon E. ; et al.	2009-02-05
RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMA App 20090036397 - Chatterton; Jon E. ; et al.	2009-02-05
RNAi-RELATED INHIBITION OF TNFalpha SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS App 20090036396 - Chatterton; Jon E. ; et al.	2009-02-05
RNAi-MEDIATED INHIBITIN OF HTRA1 FOR TREATMENT OF MACULAR DEGENERATION App 20090012030 - Chatterton; Jon E. ; et al.	2009-01-08
RNAi-MEDIATED INHIBITION OF AQUAPORIN 4 FOR TREATMENT OF IOP-RELATED CONDITIONS App 20080214486 - Chatterton; Jon E. ; et al.	2008-09-04
RNAi-MEDIATED INHIBITION OF AQUAPORIN 4 FOR TREATMENT OF OCULAR NEOVASCULARIZATION App 20080194513 - Patil; Rajkumar V. ; et al.	2008-08-14
RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF IOP-RELATED CONDITIONS App 20080171719 - Chatterton; Jon E. ; et al.	2008-07-17
Water Insoluble Polymer Matrix For Drug Delivery App 20080113027 - Asgharian; Bahram ; et al.	2008-05-15
RNAi-mediated inhibition of ocular targets App 20060172965 - Shepard; Allan R. ; et al.	2006-08-03
Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent App 20050119262 - Wax, Martin B.	2005-06-02
Methods for treating glaucoma App 20050032691 - Wax, Martin B. ; et al.	2005-02-10
Methods for treating glaucoma Grant 6,814,966 - Wax , et al. November 9, 2	2004-11-09
Compositions of an aquaporin modulating agent and an aqueous humor modulating agent for the treatment of elevated intraocular pressure App 20040213782 - Wax, Martin B.	2004-10-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.